MTCR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 13.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Metacrine Insider Trading History Chart

Metacrine Share Price & Price History

^$0.58

+0.30 (1.20%)

As of 06/20/2023 01:00 AM ET

Metacrine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/26/2023	Michael York	Insider	Sell	107,054	$0.41	$43,892.14	103,499
1/26/2023	Preston Klassen	CEO	Sell	380,605	$0.41	$156,048.05	541,905
12/21/2022	Braden Michael Leonard	Major Shareholder	Buy	120,099	$0.40	$48,039.60	6,160,570
12/19/2022	Braden Michael Leonard	Major Shareholder	Buy	101,384	$0.40	$40,553.60	5,990,349
11/9/2022	Braden Michael Leonard	Major Shareholder	Buy	39,816	$0.39	$15,528.24	5,888,965
11/7/2022	Braden Michael Leonard	Major Shareholder	Buy	123,954	$0.42	$52,060.68	5,848,649
10/28/2022	Braden Michael Leonard	Major Shareholder	Buy	45,022	$0.40	$18,008.80	5,724,695
10/26/2022	Braden Michael Leonard	Major Shareholder	Buy	588,533	$0.35	$205,986.55	4,912,166
10/24/2022	Braden Michael Leonard	Major Shareholder	Buy	174,354	$0.34	$59,280.36	3,824,354
4/19/2022	Preston Klassen	CEO	Sell	44,748	$0.50	$22,374.00	922,510

See Full Table

SEC Filings (Institutional Ownership Changes) for Metacrine (NASDAQ:MTCR)

37.72% of Metacrine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Metacrine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2023	Tang Capital Management LLC	4,250,000	$1.90M	0.3%	+147.3%	9.984%
2/13/2023	BML Capital Management LLC	6,167,458	$2.76M	2.6%	N/A	14.488%
11/15/2022	Tang Capital Management LLC	1,718,220	$0.83M	0.1%	N/A	4.036%
11/14/2022	Tudor Investment Corp Et Al	349,100	$0.17M	0.0%	N/A	0.820%
5/27/2022	ARCH Venture Management LLC	2,940,503	$1.79M	0.3%	N/A	6.924%
2/10/2022	Acadian Asset Management LLC	84,442	$56K	0.0%	N/A	0.309%
2/2/2022	Cim Investment Management Inc.	38,108	$78K	0.0%	+100.0%	0.139%
11/17/2021	ArrowMark Colorado Holdings LLC	281,467	$0.97M	0.0%	-73.1%	1.030%
11/16/2021	Two Sigma Advisers LP	136,400	$0.47M	0.0%	+176.1%	0.514%
11/16/2021	Two Sigma Investments LP	123,659	$0.42M	0.0%	+90.8%	0.466%
11/15/2021	Franklin Resources Inc.	363,600	$1.25M	0.0%	-72.2%	1.371%
11/12/2021	Renaissance Technologies LLC	283,100	$0.97M	0.0%	+254.3%	1.067%
11/12/2021	Prosight Management LP	1,145,034	$3.93M	2.2%	+31.8%	4.317%
11/9/2021	BlackRock Inc.	137,919	$0.47M	0.0%	+19.8%	0.520%
10/19/2021	Belvedere Trading LLC	29,267	$0.10M	0.0%	N/A	0.110%
9/17/2021	Virtu Financial LLC	19,671	$75K	0.0%	N/A	0.074%
9/3/2021	Parametric Portfolio Associates LLC	55,753	$0.21M	0.0%	-40.8%	0.210%
8/17/2021	Walleye Capital LLC	11,787	$45K	0.0%	N/A	0.045%
8/17/2021	Millennium Management LLC	261,420	$0.99M	0.0%	-8.9%	0.989%
8/17/2021	ArrowMark Colorado Holdings LLC	1,046,141	$3.98M	0.0%	-1.3%	3.959%
8/17/2021	Bridgeway Capital Management LLC	79,600	$0.30M	0.0%	-40.9%	0.301%
8/16/2021	New York Life Investments Alternatives	67,322	$0.26M	0.2%	+187.2%	0.255%
8/13/2021	Renaissance Technologies LLC	79,900	$0.30M	0.0%	N/A	0.302%
8/13/2021	Northern Trust Corp	12,231	$46K	0.0%	-83.0%	0.046%
8/13/2021	Geode Capital Management LLC	28,254	$0.11M	0.0%	-51.9%	0.107%
8/13/2021	Vanguard Group Inc.	408,080	$1.55M	0.0%	+65.0%	1.544%
8/12/2021	Ergoteles LLC	29,900	$0.11M	0.0%	N/A	0.113%
7/31/2021	Wedbush Securities Inc.	12,700	$48K	0.0%	N/A	0.048%
5/20/2021	Cim Investment Mangement Inc.	19,054	$0.12M	0.0%	N/A	0.072%
5/18/2021	Millennium Management LLC	286,947	$1.78M	0.0%	-12.6%	1.086%
5/17/2021	Royal Bank of Canada	48,057	$0.30M	0.0%	+13,749.3%	0.183%
5/17/2021	EcoR1 Capital LLC	62,207	$0.39M	0.0%	-81.3%	0.237%
5/17/2021	Goldman Sachs Group Inc.	10,609	$66K	0.0%	-44.3%	0.040%
5/14/2021	New York Life Investments Alternatives	23,439	$0.15M	0.1%	-33.3%	0.089%
5/14/2021	Prosight Management LP	304,485	$1.89M	1.5%	-45.9%	1.162%
5/13/2021	Bank of New York Mellon Corp	11,090	$69K	0.0%	N/A	0.042%
5/12/2021	Northern Trust Corp	71,808	$0.45M	0.0%	-7.5%	0.274%
5/12/2021	Geode Capital Management LLC	58,702	$0.36M	0.0%	+22.9%	0.224%
5/12/2021	JPMorgan Chase & Co.	313,066	$1.94M	0.0%	+334.1%	1.194%
5/7/2021	BlackRock Inc.	329,366	$2.04M	0.0%	+14.1%	1.257%
3/26/2021	Susquehanna International Group LLP	32,253	$0.25M	0.0%	N/A	0.124%
2/24/2021	Alyeska Investment Group L.P.	179,782	$1.41M	0.0%	-0.8%	0.693%
2/19/2021	JPMorgan Chase & Co.	72,116	$0.57M	0.0%	N/A	0.278%
2/16/2021	Alyeska Investment Group L.P.	179,782	$1.41M	0.0%	-0.8%	0.693%
2/16/2021	Nuveen Asset Management LLC	10,906	$86K	0.0%	N/A	0.042%
2/16/2021	New York Life Investments Alternatives	35,150	$0.28M	0.2%	N/A	0.135%
2/16/2021	Charles Schwab Investment Management Inc.	13,800	$0.11M	0.0%	N/A	0.053%
2/13/2021	American International Group Inc.	3,843	$30K	0.0%	N/A	0.015%
2/11/2021	Northern Trust Corp	77,648	$0.61M	0.0%	N/A	0.299%
2/9/2021	Wells Fargo & Company MN	3,460	$27K	0.0%	N/A	0.013%
2/5/2021	BlackRock Inc.	288,571	$2.27M	0.0%	+224.9%	1.112%

Data available starting January 2016

See Full Table

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $0.58

$0.58

$0.59

50 Day Range

MA: $0.57

$0.55

$0.59

52 Week Range

Now: $0.58

$0.30

$0.59

Volume

83,889 shs

Average Volume

225,834 shs

Market Capitalization

$24.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A